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Drosophila dMyc (dMyc) is known for its role in cell-autonomous regulation of growth. Here we address
its role in the fat body (FB), a metabolic tissue that functions as a sensor of circulating nutrients to control
the release of Drosophila Insulin-like peptides (Dilps) from the brain inﬂuencing growth and develop-
ment. Our results show that expression of dMyc in the FB affects development and animal size.
Expression of dMyc, but not of CycD/cdk4 or Rheb, in the FB diminishes the ability to retain Drosophila
Insulin-like peptide-2 (DILP2) in the brain during starvation, suggesting that expression of dMyc mimics
the signal that remotely controls the release of Dilps into the hemolymph. dMyc also affects glucose
metabolism and increases the transcription of Glucose-transporter-1 mRNA, and of Hexokinase and
Pyruvate-Kinase mRNAs, key regulators of glycolysis. These animals are able to counteract the increased
levels of circulating trehalose induced by a high sugar diet leading to the conclusion that dMyc activity in
the FB promotes glucose disposal. dMyc expression induces cell autonomous accumulation of triglycer-
ides, which correlates with increased levels of Fatty Acid Synthase and Acetyl CoA Carboxylase mRNAs,
enzymes responsible for lipid synthesis. We also found the expression of Stearoyl-CoA desaturase, Desat1
mRNA signiﬁcantly higher in FB overexpressing dMyc. Desat1 is an enzyme that is necessary for
monosaturation and production of fatty acids, and its reduction affects dMyc's ability to induce fat
storage and resistance to animal survival.
In conclusion, here we present novel evidences for dMyc function in the Drosophila FB in controlling
systemic growth. We discovered that dMyc expression triggers cell autonomous mechanisms that control
glucose and lipid metabolism to favor the storage of nutrients (lipids and sugars). In addition, the
regulation of Desat1 controls the synthesis of triglycerides in FB and this may affect the humoral signal
that controls DILP2 release in the brain.
& 2013 Elsevier Inc. All rights reserved.Introduction
Myc activity controls fundamental processes including animal
development, cell proliferation, and tissue growth (Bellosta and
Gallant, 2010; Dang, 2012). In Drosophila mutations in the sole
dmyc gene reduce body size (hence the name diminutive)
(Johnston et al., 1999) and analysis of dmyc’s target genes reveals
a high prevalence for genes regulating ribosome biogenesis and
protein synthesis (Grewal et al., 2005; Hulf et al., 2005; Orian et al.,
2003). Myc activity lies downstream of numerous growth factorsll rights reserved.
and Development, Columbia
. Fax: +212 305 9090.
).and nutrient signaling pathways including the SWH (Salvador–
Warts–Hippo) pathway, to control growth in epithelial cells
(Huang et al., 2005; Neto-Silva et al., 2010; Ziosi et al., 2010),
and of the insulin/TOR signaling pathway, that regulates dMyc
protein stability through the ubiquitin degradation pathway (Parisi
et al., 2011; Zhang et al., 2006). Myc function is known to control
metabolic pathways upstream of glycolysis and glutaminolysis
(Osthus et al., 2000; Wise et al., 2008), particularly in cancer cells
where c-Myc activity couples glucose and glutamine metabolism
with growth and biomass (Dang, 2012; Yuneva et al., 2012). Much
less is known about the role of Myc in the regulation of lipid
metabolism. A few studies pinpoint at the ability of adipocytes and
liver cells to increase c-myc mRNA in response to caloric restric-
tion, suggesting that Myc may be necessary to maintain the basal
metabolic rate of these cells during low nutrient conditions
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strated that animals expressing c-myc in the liver showed increase
blood glucose disposal and resistance to streptozotocian-induced
diabetes. These animals favor glycolysis and lipogenesis (Valera
et al., 1995), suggesting a function for Myc in the regulation of
carbohydrate metabolism in non-cancerous conditions (Riu et al.,
1996).
In Drosophila, the fat body (herein referred as FB) is a metabolic
tissue with similar physiological functions as the mammalian adipose
tissue and liver. The FB acts as storage for sugars and fats, which are
mobilized to sustain basal cellular energy supplies when nutrients are
scarce (Liu et al., 2009), and regulates systemic growth in response to
nutrients and hormonal signals (Tennessen and Thummel, 2011). The
FB functions as a sensor for amino-acids in the hemolymph (Britton
and Edgar, 1998; Davis and Shearn, 1977), and when their concentra-
tion is abundant, releases humoral factors to remotely control the
release of Drosophila insulin like peptide 2 (DILP2) from the Insulin
Producing Cells (IPCs) (Geminard et al., 2009; Ikeya et al., 2002). The
signals that control the production of these factors in the FB and their
identity have not been elucidated yet. Recently, the expression of
Dilp6, a member of the Drosophila Insulin like peptide produced by the
FB, was shown to negatively regulate DILP2 release in the brain of
adult ﬂies (Bai et al., 2012). In addition, Unpaired (Upd2), a cytokine
member of the unpaired family secreted from the FB, was also shown
to control DILP2 release and to reduce systemic growth (Rajan and
Perrimon, 2012). dMyc expression in the FB, was reduced at late third
instar by ecdysone signaling to reduce growth allowing the onset of
metamorphosis to proceed (Delanoue et al., 2010), while the opposite
was shown in animals during starvation where dmycmRNA in FB was
sustained by dFOXO transcriptional activity (Teleman et al., 2008)
probably to maintain the basal metabolic rate necessary for the animal
to survive.
We decided to use the Drosophila FB to identify the key effectors
that couple Myc activity to changes in metabolic pathways essential
for animal growth and survival. With this study, we were able to
demonstrate that expression of dMyc in the FB induces systemic
growth and confers resistance to starvation. Animals expressing dMyc
in the FB have acquired the ability to facilitate DILP2 release from the
IPCs, suggesting that dMyc activity affects the humoral signals in the
FB that control DILP2. These animals have increased levels of sugars in
the FB and transcription of Glucose-transporter-1 mRNA, Hexokinase-A
and Hexokinase-C and Pyruvate-KinasemRNAs and are able to counter-
act trehalosemia induced by high sugar diet. dMyc also increases the
level of triglycerides, which correlates with increased levels in the FB
of Fatty Acid Synthase, Acetyl CoA Carboxylase mRNAs and of Stearoyl-
CoA desaturase, Desat1 mRNA. Desat1 is the Drosophila orthologue of
the vertebrate Stearoyl-CoA desaturase-1/SCD1, a key enzyme neces-
sary for the formation of monosaturated fatty acids and lipid biosynth-
esis (Mauvoisin andMounier, 2011). Desat1 function is conserved from
Drosophila to vertebrates (Brock et al., 2007; Kohler et al., 2009), where
mutations in SCD1 result in a dramatic reduction of body fat, insulin
sensitivity and reduced overall animal size (Ntambi et al., 2002; Zheng
et al., 1999). Our data show that expression of Desat1 in the FB is
necessary for dMyc-induced regulation of systemic growth, fat storage
and resistance to starvation, placing this enzyme as a novel compo-
nent in dMyc's function in controlling lipid metabolism and systemic
growth.Materials and methods
Fly husbandry
cg-GAL4 (Bloomington stock 7011), UAS-GS1 RNAi (Bloomington
stock 40836), UAS-dMyc RNAi (VDRC stock 2947 and Bloomington
stock 25784), UAS-Pyruvate Kinase RNAi (VDRC stock 49533),UAS-Hexokinase-C RNAi (VDRC stock 35337) and UAS-Desat1 RNAi
(VDRC stock 33338). UAS-HA-dMyc (Bellosta et al., 2005), yw
hs-Flp122; Act5C4FRT-CD2-FRT4Gal4; UAS-GFP/TM6b (Saucedo
et al., 2003), hemolectin-GAL4 (Goto et al., 2001), pumpless-GAL4
(Zinke et al., 1999). Animals were raised at low density, at 25 1C on
a standard corn meal containing 6 g/L agar, 75 g/L corn ﬂour,
100 g/L white sugar, 50 g/L fresh yeast, and 10 g/L inactivated yeast
powder, along with nipagin and propionic acid (Acros Organic).
Nile-red and oil-red O tissue staining
For Nile-Red: Larvae were bisected in PBS. Fat bodies were
isolated from carcasses, ﬁxed for 20 min in 4% paraformaldehyde
(Electron Microscopy Science) in PBS, washed in 0.3% PBS triton
X-100 and incubated for 30 min in a 0.01 mM Nile Red Solution
(SIGMA), then photographed under a Zeiss LSM510 confocal
microscope. Oil Red O staining of larval tissues was performed as
described previously (Gutierrez et al., 2007).
Quantitative real time PCR
Total RNAwas isolated using RNeasy Mini Kit (Qiagen) according to
the manufacturer's instructions. Extracted RNAs were quantiﬁed using
a UV spectrophotometer and RNA integrity was conﬁrmed with
ethidium bromide staining. The puriﬁed RNA (1 μg) was used as
template for cDNA synthesis using SuperScript II (Invitrogen). The
SYBR Green PCR Kit (Qiagen) was used, and products were quantiﬁed
using the ABI Prism 7300 system. The relative level for each gene was
calculated using the 2-DDCt method (Hulf et al., 2005) and reported as
arbitrary units compared to actin5C as a control. At least three separate
experiments were performed in duplicate. Primers were designed
using Primer3 (Rozen and Skaletsky, 2000). Primers list in available in
the Supplementary materials.
Starvation assay
At least 30 staged late L2 larvae from each genotype for each
replica were collected and transferred in single well plastic plates
containing paper soaked with PBS; survival rate was determined
every 12 h. These experiments were repeated three times. Statistical
analysis was performed using a z-test (Supplementary Appendix A).
Larval development
At least 30 staged L1 larvae (24 h AED) of each genotype were
collected in grape agar and transferred into regular corn meal
food. The developmental stage was scored every 12 h and identi-
ﬁed according to the mouth hook/spiracle morphology (Britton
and Edgar, 1998). To quantify growth differences, age-matched
larvae were collected from the culture medium, washed and killed
by microwave pulse. Larval volume was measured using Photo-
shop software and the formula 4/3π(L/2)(l/2)2 (L¼ length l¼width)
was used.
Glucose and triglyceride measurement
Trehalose and TAG levels were measured in both fed and starved
larvae. 72 h larvae were either kept in normal ﬂy food or starved for
24 h in petri dishes containing ﬁlter paper moistened with PBS. Five to
ten larvae were homogenized on ice in 200 ml of PBS for glucose
assays, or in 0.1% PBS Tween for triglyceride assays. Homogenates
were centrifuged for 3 min at 5000 rpm and the supernatants were
incubated at 70 1C for 5 min to inactivate endogenous enzymes. For
glucose assays, trehalosewas converted to glucose by adding Trehalase
(Sigma) at a ﬁnal concentration of 0.025 U/ml and incubating for
15 min at 37 1C. The samples were mixed with 500 ml of Glucose
Fig. 1. Expression of dMyc in the FB non-autonomously affects animal size. (A) Western blot showing dMyc protein expression in lysates from FB of third instar larvae. dMyc
proteins are visible as 100 and 130 KDa bands that are recognized by anti-dMyc antiserum (Prober and Edgar, 2002), and as an 100 KDa band that is recognized by anti HA tag
antibodies only present in the extract from cg-HA-dMyc larvae. Actin was used as a control for loading, (B) photographs of third instar larvae, (C) measurement of larval growth;
values are expressed in larval volume (mm3) and hours after egg laying (AEL) at 25 1C. Two lines for each UAS-dMyc or UAS-dMyc-RNAi were used. The P-values from a Student
t-test at 120 h of development are P¼0.008 for cg-dMyc on Chr II and P¼0.01 for cg-dMyc on Chr III. In cg-UAS-dMyc-RNAi animals the total duration of larval development was
altered, with pupation reached at 168 h AEL compared to 120 h in cg-control or cg-dMyc animals, L1/L2 and L2/L3 transitions were unaffected; a t-test of Po0.001 was
calculated for both cg-dMyc-RNAi lines in all the time point of development. Error bars indicate the standard deviation from four independent experiments; approximately 50
larvae for each time point were used. (D) Adult females. (E) Body weight, pupal length and measurement of growth in the eye was calculated by measuring the size of single
ommatidia as a measurement of cell size and their total number in each eye as measurement for proliferation. Growth in the wing was calculated by measuring the size of a
trichome for cell size, and their total number for proliferation. The total wing area was calculated as in the material and methods. Data are expressed as % of cg- control ﬂies
(n¼20) for female ﬂies. *Po0.05, **Po0.01, ***Po0.001; P-values were calculated from a Student t-test. Off note: all the lines used were isogenic for the yw-1118 chromosome. No
signiﬁcant differences in the timing of development and body size were observed in the parental lines used in those crosses (Supplementary Fig. 13A and B).
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measured at 340 nm according to themanufacturer's protocol. Glucose
measurements from undigested samples were subtracted to give the
amount of glucose obtained from trehalose. For hemolymph assays,
hemolymph was pooled from 5 larvae and 1 μl collected, diluted 1:20
in PBS, and heat inactivated at 70 1C for 5 min. 2 μl of diluted
hemolymph was used for each glucose assay. Triglyceride measure-
ments were performed by incubating 20 ml of sample with 400 ml of
Free Glycerol Reagent (Sigma) for 15 min at RT, followed by 100 ml
Triglyceride Reagent (Sigma) for 15 min, and absorbance read at
540 nm according to the manufacturer's protocol. Glucose and trigly-
ceride concentrations were normalized against total protein concen-
tration in each sample as measured by a BCA assay (Pierce). Assays
were repeated a minimum of three times. Triglycerides were also
measured in fat bodies collected from ten larvae per genotype.
Western blot
Tissues from staged third instar larvae were collected in lysing
buffer (50 mM Hepes pH 7.4, 150 mM NaCl, 1% Triton, 1 mM EDTA),
with phosphatase and protease inhibitors (Roche). Proteinconcentrations were quantiﬁed using Bradford reagent. Equal
amounts were resolved on 8% SDS-PAGE gels and transferred to
nitrocellulose membranes. Western blotting was performed using
mouse monoclonal anti dMyc antibody (Prober and Edgar, 2002),
rat monoclonal anti epitope tag HA antibody (Roche) and mouse
monoclonal anti-actin antibody (Millipore). Enhanced chemilumi-
nescence (ECL-GE Healthcare) was used for detection. Quantiﬁca-
tion of dMyc proteins was performed from photographs using
ImageJ. The intensity of each band (pixels) was compared to the
intensity of the same band in cg- control from the same blot.
Anti-DILP2 and anti dFOXO immunoﬂuorescence
Brains from larva at 96 h AEL were dissected in PBS, ﬁxed in
PBS/4% formaldehyde for 20 min, and washed in PBS-0.3% Triton
X-100 (PBT). Tissues were blocked in PBT/5% BSA. Primary rat-anti-
DILP2 was used overnight at 4 1C (Geminard et al., 2009) followed
by Alexa488 anti rat-secondary antibodies (Invitrogen). Tissues
were mounted in Vectashield with DAPI (Vectorlabs) and ﬂuores-
cence images were acquired using a Zeiss LSM 510 confocal
microscope. The quantiﬁcation of the mean pixels corresponding
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the histogram tool in ImageJ, using similar parameters as
described previously (Geminard et al., 2009). Data are expressed
in arbitrary units, and represent the average ﬂuorescence intensity
in the IPCs and relative standard deviations were calculated using
four independent experiments, each including at least ten animals
of each genotype and conditions. dFOXO staining FBs from larva at
96 h AEL or starved for 24 h in PBS, were dissected in PBS, ﬁxed in
PBS/4% formaldehyde for 20 min, and washed in PBS-0.3% Triton
X-100 (PBT). Tissues were blocked in PBT/5% BSA. Primary rat-anti-
dFOXO was used overnight at 4 1C followed by Alexa-488 anti
rat-secondary antibodies (Invitrogen). Tissues were mounted in
Vectashield with DAPI (Vectorlabs) and ﬂuorescence images were
acquired using a Zeiss LSM 510 confocal microscope. The anti
dFOXO antibody was developed during this study using the region
CASMETSRYEKRRGRAKKRVEALR from the Drosophila peptide
sequence as an antigen. The peptide was linked to a protein
carrier and injected into rabbit. The serum was afﬁnity puriﬁed
using the peptide used as antigen and AP anti-dFOXO used 1:200
(Prosci-inc, CA).Proteomics
Three independent collections of FB from third instar larvae of
the different genotypes were harvested in 0.66% Rapigest (Waters
Corp.) with dithiothreitol (6 mM), sonicated, boiled and digested
to peptides with trypsin. Analysis of peptides was performed at
the Quantitative Proteomics Center at Columbia University using
an ultrahigh-pressure liquid chromatograph and a quadrupole-
time-of-ﬂight mass spectrometer using methods described
previously (Oswald et al., 2011). This system uses a shotgun prot
eomics method called MSE in which mass spectra are recorded at
alternate low (precursor) and high (product) fragmentation vol-
tages (Silva et al., 2006), resulting in a more complete representa-
tion of the intensity of a peptide in a chromatographic peak.
Peptides were analyzed in a LC/MS run on a 0.75 μm ID25 cm
reverse phase 1.7-μm particle diameter C18 column at a ﬂow rate
of 300 nL/min with an acetonitrile/formic acid gradient on a
NanoAcquity UPLC (Waters Corp.). Spectra were recorded with a
0.6 s scan time with a Synapt mass spectrometer (Waters Corp).
MS and MSE spectra were analyzed with ProteinLynx Global Server
(PLGS) software (Waters Corp.). In addition to PLGS software, we
used the Elucidator Protein Expression Data Analysis System
software (Rosetta Biosoftware). This program provided multivari-
ate statistical analysis tools, principal components analysis,
ANOVA, and hierarchical cluster analysis for analyzing these data.Table 1
The indicated UAS-transgenes were expressed in the fat body using the cg-Gal4 promot
chromosomal insertions.
Genotype Pupal length (mm) Days of development a Adul
cg-Gal4/+ ; +/+ 3.0570.07 (63) 10.7270.31 (443) 099.8
cg-Gal4/UAS-dMyc (II); +/+ 3.2470.07 (52) *** 11.2770.07 (287) 100.0
cg-Gal4/+; UAS-dMyc (III)/+ 3.1870.09 (46) *** 11.5070.22 (356) 099.2
cg-Gal4/UAS-dMyc-RNAi (II); +/+ 2.8070.14 (48) *** 12.9070.37 (304) 054.8
cg-Gal4/+; UAS-dMyc-RNAi (III)/+ 2.3570.17 (20) *** PL PL
cg-Gal4/UAS-dMyc (II);
UAS-dMyc-RNAi (III) /+
3.0470.14 (55) 11.3070.14 (225) 067.7
a From egg-deposition until adults eclosion.
b Data were calculated as % of the total animals of the expected genotype.
c See materials and methods for calculation. PL: pupal lethal. nd: not determined.
nnn P-value from t Student test is Po0.001 compared to cg-Gal4. In parenthesis is thResults
dMyc expression in the fat body affects animal size
To understand whether Myc activity in adipocytes regulates
metabolic pathways that affect growth and survival, we modulated
dMyc expression in the larval fat body (FB), using the UAS-Gal4
binary system (Brand et al., 1994). The cg (collagen type IV)
promoter (Asha et al., 2003) fused with Gal4, was used to drive
expression of UAS-dMyc or UAS-dMyc-RNAi in the FB. dMyc protein
expression was analyzed in FB from yw1118; cg-Gal4; UAS-HA-dMyc
(hereinafter called cg-dMyc), yw−1118; cg-Gal4; UAS-dMyc-RNAi
(hereinafter called cg-dMyc-RNAi), and yw1118; cg-Gal4 (hereinafter
called cg-) third instar larvae, using anti dMyc antibodies (Prober
and Edgar, 2002). These data showed that in the FB anti dMyc
antibodies recognize two major bands of 100 and 130 KDa bands
that were signiﬁcantly reduced in extracts from cg-dMyc RNAi FBs
(Fig. 1A, left panel). However, since dMyc was expressed with an
HA tag, we were able to use anti-HA antibody to detect one band
at 100 KDa that was present only in the extracts of FB from cg-HA-
dMyc larvae (Fig. 1A, right panel). Analysis of organismal size and
developmental delay revealed that cg-dMyc animals develop with
a similar rate as cg larvae (Fig. 1C and Table 1), but they reach
pupation at a signiﬁcantly bigger size than control animals. Similar
results were obtained using two independent insertions of UAS-
dMyc (t-test P-valueso0.05 for both lines). In contrast, RNAi-
mediated reduction of dMyc in the FB resulted in animals that
reached pupation with a delay of 48 h at their third instar
transition (Fig. 1C and Table 1); these animals were smaller
throughout development (Po0.0001 in a t-test when compared
to cg- larvae) and eclosed as small adults (Fig. 1B–D and E). Two
independent chromosomal insertions were used for these experi-
ments, and the dMyc-RNAi line on Chromosome III resulted in
larval lethality, a defect that was rescued by coexpression of UAS-
dMyc (Table 1, and Supplementary Fig. 1). Phenotypic analysis of
the adult animals showed that cg-dMyc ﬂies were 17% heavier than
control cg- animals (Fig. 1D,E), on the contrary, RNAi-mediated
reduction of dMyc resulted in ﬂies that eclosed with and with
signiﬁcantly reduced body size and weight (Fig. 1D,E and Table 1)
and two days of delay (Supplementary Fig. 1B). To assess whether
the differences in body weight measured in cg-dMyc and cg-dMyc-
RNAi adults animals reﬂected changes in the size of the peripheral
organs, we measured the cell size and number in the wing and the
eye of adult animals. In the wing blade each cell is accessorized
with a single bristle called trichome. We measured the number of
trichomes in a deﬁned area of the wing blade in animals of the
three different genotypes. This analysis revealed that ﬂies expres-
sing dMyc in the FB had an increased size and number of the cellser. Two different lines were used for UAS-dMyc and UAS-dMyc-RNAi with different
ts at eclosion (%)b Area wing (mm2)c Size of thricome
(mm2)c
Total number of
thricomes/wingc
(443) 1.9670.06 (16) 13379.5 (16) 1471371094 (16)
(287) 2.2470.06 (16) *** 14976.1 (16) *** 1506071094 (16)
(356) nd nd nd
(304) 1.4070.10 (16) *** 11376.1 (16) *** 1240470980 (16) ***
PL PL PL
(225) 1.6670.11 (16) 12579.2 (16) 1325971310 (16)
e total number of animals in the experiments.
Fig. 2. dMyc expression in the FB remotely affects DILP2 release from the insulin producing cells (IPCs) and reduces the level of trehalose in the hemolymph. (A) Third instar
larvae were raised in corn meal food then starved for 24 h in PBS. Anti-DILP2 ﬂuorescence was quantiﬁed as described previously (Geminard et al., 2009). P values were
calculated from a Student t-test from n¼10 larvae for each time point and genotype and four independent experiments. (B) dMyc systemic growth is abolished in dilp2, 3,5
mutant background. Growth was measured in the wing of adult females ﬂies of the indicated genotype and expressed in mm2. P-values were calculated from Student t-test
from n¼15 adults for each genotype, from two independent experiments. (C) Quantiﬁcation of trehalose (mM) in the hemolymph of cg- control and cg-dMyc larvae in
feeding and after starvation. ***Po0.001 value was calculated from three independent experiments. Error bars represent the standard deviations.
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expression of dMyc in the FB increases the size of the wings, thus
peripheral organs. On the contrary, cg-dMyc-RNAi animals dis-
played an opposite phenotype with wings that were smaller due
to a reduced number and size of their cells (Fig. 1E, Po0.0001 in a
t-test). Similar conclusions were obtained when the analysis was
performed in the ommatidia that constitute the compound eye
(Fig. 1E). dMyc effect on systemic growth was speciﬁc for its
activity in the fat cells since we obtained similar results using
pumpless-Gal4 (Zinke et al., 1999) that also drives the expression in
the FB (Supplementary Fig. 2). Since the cg promoter is active in
the FB and in the hemocytes (Asha et al., 2003), we used the
hemolectin-Gal4 (Goto et al., 2003) and Serpent-hemocytes-Gal4
(Bruckner et al., 2004) to show that expression of dMyc in
hemocytes was not associated with any alteration in develop-
mental timing or body size (Supplementary Fig. 3). In order to
understand whether the systemic growth induced by dMyc was
associated with its role in increasing the cell size of the FB, we
expressed the growth inducers cyclin D/Cdk4 (Prober and Edgar,
2002) and Rheb (Patel et al., 2003; Saucedo et al., 2003; Stocker
et al., 2003) and cell size and organismal size were measured. This
analysis showed that even though expression of dMyc, CycD/Cdk4
or Rheb induced cell-autonomous growth (Supplementary Fig. 4),
only expression of dMyc was able to induce growth at the
organismal level (Fig. 1E). Taken together these data suggest that
increasing dMyc activity in the FB speciﬁcally induces systemic
growth.
dMyc expression in the FB affects DILP2 release from the insulin
producing cells
During feeding, the FB remotely controls DILP2 release from the
brain by secreting factors in the hemolymph to induce the release
of DILP2 from the insulin producing cells (IPCs) (Geminard et al.,
2009). Given the systemic effect on growth by dMyc expression in
the FB we analyzed if misexpression of dMyc in the FB affects
DILP2 protein localization within the IPCs. Animals were grown in
corn medium then starved in PBS, and DILP2 protein in the IPCs
was quantiﬁed by immunoﬂuorescence. This analysis showed that
while DILP2 protein accumulates in the IPCs of cg-control larvae
after starvation (Po0.001, in a t-test), in cg-dMyc animals this
regulation was absent and the intensity of ﬂuorescence in the IPCs
was similar in animals in feeding or starving conditions (P¼0.957)
(Fig. 2A, Supplementary Fig. 5). On the contrary, animals with
reduced dMyc levels in the FB showed an accumulation of DILP2 in
the IPCs when kept in feeding conditions (Fig. 2A, P¼0.004, in a t-
test and Supplementary Fig. 5). The lack of DILP2 protein accu-
mulation after starvation in cg-dMyc animals was attributablemainly to changes in DILP2 protein since dilp2 mRNA levels did
not change in these animals (Supplementary Fig. 6A–D). To analyze
if DILP2 activity was solely responsible for mediating the systemic
growth induced by dMyc, we expressed dMyc in the FB of dilp2,3,5
mutant animals. dilp2,3,5 homozygous mutant ﬂies are viable and
hatch as small adults with a delay of about 14 days (Gronke et al.,
2010). These experiments, showed that reduction of dilp2,3, 5
expression blocked the effect of dMyc on systemic growth (Fig. 2B,
P¼0.114) suggesting that dMyc activity in the FB requires func-
tional dilps signaling to induce systemic growth. The use of a triple
mutant background was necessary to avoid compensatory effects
between the different dilps (Broughton et al., 2008; Ikeya et al.,
2002). dilp2, 3 and 5-mRNAs levels in the IPCs did not vary among
the three different genotypes (Supplementary Fig. 6A,B), however
we measured a signiﬁcant decrease in the of dilp2, 3 and 5-mRNAs
levels in cg-control animals upon starvation, which was not visible
in brains from cg-dMyc larvae (Supplementary Fig. 6C,D).
DILPs stimulate the uptake of circulating sugars from the
hemolymph (Rulifson et al., 2002; Tatar et al., 2003), and their
levels in the IPCs are inversely proportional to the amount of
circulating trehalose (larval sugar) (Geminard et al., 2009). Treha-
lose is a dimer of two molecules of glucose and is transported as a
monomer through the hemolymph to the tissues where it is
uptaken by a class of glucose transporters (Escher and Rasmuson-
Lestander, 1999). During starvation, the concentration of trehalose
decreases over time, as a direct result of DILP2 retention in the IPCs
(Dus et al., 2011; Luo et al., 2012) hence we decided to measure the
level of trehalose in the hemolymph as an indirect readout for
DILP2 activity. This analysis showed that in starvation the levels of
circulating trehalose in cg-dMyc animals decreased more rapidly
then in cg-control larvae (Fig. 2C, and Supplementary Fig. 7),
indirectly supporting the hypothesis that cg-dMyc larvae have
higher concentration of circulating DILP2 than cg- control animals.
dMyc expression in the FB increases sugar storage, glycolytic enzymes
and counteracts increased glycemia
We then analyzed whether the expression of dMyc in the FB
affects the storage and mobilization of trehalose in the whole
animal. cg-dMyc larvae raised on regular food, displayed a sig-
niﬁcant increased in trehalose concentration in the whole body,
whereas cg-dMyc-RNAi animals, of same developmental stage,
showed the opposite effect (Fig. 3A). After 24 h of starvation,
trehalose levels were reduced with a similar ratio in all three
genotypes indicating that dMyc in the FB did not inﬂuence sugar
mobilization. Analysis of enzymes responsible for glucose meta-
bolism, showed an increase in the level of the glucose transporter
Glut1-mRNA, and of the glycolysis enzymes Hexokinase-C and
Fig. 3. Expression of dMyc in the FB affects glucose metabolism. (A) Trehalose in the whole larvae was measured from animals in fed and starving conditions. P-values were
calculated from a Student t-test using 10 larvae per genotype in each time point from four independent experiments. Trehalose was normalized to protein concentration,
(B) quantitative RT-PCR in FB from third instar larvae showing the indicated transcript levels in cg-control, cg-Myc and cg-dMyc-RNAi animals; actin5C was used as the
internal control. *Po0.05, **Po0.01, ***Po0.001; P-values were calculated from a Student t-test from at least four independent experiments, (C) quantiﬁcation of trehalose
(mM) in the hemolymph of cg- control and cg-dMyc larvae in medium containing 0.15 M or 1 M sucrose (Musselman et al., 2011). P-values were calculated from a Student
t-test from n¼15 cg- and cg-dMyc larvae in different sucrose concentrations. Error bars represent the standard deviations.
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addition, we found that expression of dMyc correlated with the
increased level of dilp6-mRNA. DILP6 is expressed in the FB and
produced during the non-feeding stage (Okamoto et al., 2009;
Slaidina et al., 2009; Zhang et al., 2009). In adult ﬂy, dilp6
transcription is regulated by dFOXO and correlates with a decrease
in DILP2 release, resulting in reduced insulin signaling (Bai et al.,
2012).
Transgenic mice expressing c-myc in the liver maintain lower
glycemia after treatment with streptozotocin, a drug that causes a
predisposition to diabetes (Riu et al., 1996). We analyzed whether
a similar mechanism was also present in ﬂies. Feeding larvae a
high-sugar diet (HSD) increases sugars in the hemolymph
(Musselman et al., 2011), and while cg- animals fed a HSD
exhibited a rise in circulating trehalose (Fig. 3C, Po0.05), the
cg-dMyc counterparts maintained an invariant trehalosemia
(Fig. 3C, P¼0.159). These data support the idea that dMyc in the
FB is able to reduce the level of sugars in the hemolymph via a
remote control of dilps and through a tissue autonomous regula-
tion of glucose uptake in FB. In vertebrates, increase in glucose
metabolism is associated to glutamine uptake to promote cell
survival (Wellen et al., 2010), in addition, c-myc induces the
consumption of glutamine to favor growth in cancer cells (Wise
et al., 2008). In cg-dMyc FBs, we found increased expression of
Glutaminase (CG42708) and of Glutamine synthetase1 (GS1)
mRNAs, suggesting that dMyc may control glutamine metabolism
in Drosophila FB.
dMyc expression in the FB affects storage of TAG and survival in low
nutrient conditions
Morphological analysis of FBs, using the lipid-speciﬁc dye Nile
Red, revealed that fat cells from cg-dMyc animals contained
cytoplasmic lipid droplets smaller in size then in
cg- controls (Fig. 4A,B and E). This effect was more exacerbated
in clones expressing dMyc using the actin-promoter
(Supplementary Fig. 8A). On the contrary, the lipid droplets from
cg-dMyc-RNAi FB cells were abnormally enlarged (Fig. 4C and E,
and Supplementary 8B) resembling vesicles from starved animals
(Fig. 4D). Analysis of the cell size and triglyceride (TAG) content
showed that fat cells from cg-dMyc animals were larger (Fig. 4F)
and contained more TAG per protein compared to cg-control
(Fig. 4G). The opposite effect was observed in FB from cg-dMyc-
RNAi animals. Increased levels of TAG result from increased
synthesis or reduced degradation of fatty acids. Thus we analyzed
if the expression of speciﬁc enzymes involved in fatty acid
metabolism were affected by dMyc expression. This analysis
revealed that FBs from cg-dMyc animals have increased levels ofPerilipin2-mRNA, the orthologue of the vertebrate lipid storage
droplet gene-2 (LSD-2) (Bickel et al., 2009), a protein that func-
tions to regulate lipid storage and favors lipogenesis (Gronke et al.,
2003; Okumura, 2011; Tansey et al., 2001). In addition, we found
increased expression of CG11198 and CG3524 (Palanker et al.,
2009), encoding for putative orthologues of the vertebrate
Acetyl-Co Carboxylase (ACC) and Fatty Acid Synthase (FAS) respec-
tively. dMyc also upregulates the expression of CG5887-Desat1
mRNA (Wicker-Thomas et al., 1997), the orthologue of the verte-
brate Stearoyl CoA Desaturase (SDC1) an enzyme that has been
associated together with ACC and FAS with the control of de-novo
synthesis of lipids in the liver (Paton and Ntambi, 2009). On the
contrary, the expression of CG2107-mRNA (Palanker et al., 2009),
encoding for a putative orthologue of a carnitine transporter, a key
regulator of beta-fatty acid oxidation was reduced in cg-dMyc FB
(Fig. 4H), indicating that the fat cells in these animals have
increased fatty synthesis and reduced oxidation.
Lipids stored principally in the mid-gut and gastric caeca, are
cleared from those tissues during starvation and accumulate in the
oenocytes, a cluster of cells with functions similar to the vertebrate
liver (Gutierrez et al., 2007). To analyze whether dMyc expression
in the FB affects lipid mobilization, third instar larvae were
starved, and lipid content was visualized in feeding and after
starvation using Oil Red O (Palanker et al., 2009). In feeding
conditions lipids were present more abundantly in the mid-gut
and gastric caeca of cg-dMyc animals (Fig. 4I middle panel). These
animals also showed the presence of lipid vesicles in their
oenocytes, which during feeding are normally emptied of lipids
(compare insets in the left and middle panel). After 24 h of
starvation, lipids were equally cleared from the mid-gut and caeca
from all three genotypes and accumulate in the oenocytes with no
difference between the three genotypes (Fig. 4I, lower panels).
Measurement of TAG from whole animals in feeding conditions
conﬁrmed that cg-dMyc larvae have a small but signiﬁcant
increase in the level of TAG compared to cg- controls (Po0.05),
while cg-dMyc-RNAi displayed a dramatic reduction in their lipid
content (Po0.001) (Fig. 4J). Upon starvation the TAG stores were
reduced at a similar rate in all three genotypes, suggesting that
expression of dMyc in FB does not affect lipid mobilization.
Animals store triglycerides and sugars to survive periods of
scarce nutrient availability. We analyzed whether the differences
in the content of sugars (Fig. 3A) and TAG (Fig. 4J) between the
animals of the three genotypes could affect their ability to survive
starvation. Animals were raised in normal food until they reached
the mid-second larval instar, at which point they were transferred
to PBS and their viability scored every 12 h. These experiments
showed that whereas only 50% of cg- control survived after 80 h of
starvation, the half-life of cg-dMyc animals during starvation
Fig. 4. Altered dMyc expression in the FB increases triglycerides (TAG) and confers resistance to starvation. (A–D) Photographs of FB from third instar larvae of the indicated
genotypes. Lipid vesicles are stained with Nile Red, nuclei with DAPI and Alexa-488-Phalloidin to visualize the cell membrane, (E) size of the vesicles in fat cells was analyzed
from photographs (A–C), (F) size of cells in the FB (G) triglyceride (TAG) content in cells from the FB; TAG concentration was normalized to the amount of protein; P-values
were calculated from a Student t-test from four independent experiments, 10 larvae in each experiment were used; (H) quantitative RT-PCR from FB from third instar larvae
from cg-control, cg-Myc and cg-dMyc-RNAi animals; actin5C was used as control. *Po0.05, **Po0.01, ***Po0.001; P-values were calculated from Student t-test from at least
four independent experiments, (I) oil red O staining of midgut, caeca, and oenocytes (insets) dissected from larvae of the indicated genotype fed (upper panel) or starved for
24 h in PBS (lower panel). Insets show oenocytes stained with Nile Red, (J) content of triglycerides (TAG) was normalized to protein concentration in whole larvae in feeding
and after starvation in PBS. P-values were calculated from Student t-test from at three independent experiments, (K) age-matched late L2 larvae were transferred in PBS, and
larval viability was calculated every 12 h. cg-dMyc larvae show resistance to starvation when compared to cg-control animals, while the opposite was shown by cg-dMyc-
RNAi animals Po0.001 in a z-test for the survival rate between the three genotypes (see Appendix-A for calculation). Error bars represent the standard deviations.
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statistic analysis). Conversely, cg-dMyc-RNAi larvae reached their
half-life at about 56 h of starvation (Fig. 4K) (Po0.0001, in a
z-test).
From these data, we conclude that expression of dMyc in FB
locally and remotely increases lipid concentration and storage, and
correlates with a better survival during nutrient starvation.
Reduction of Desat1 in FB, but not of PyK and HK-C affects the ability
of dMyc to induce systemic growth
The increase of dMyc expression in the FB during starvation
(Fig. 5A) is induced by the transcription factor FOXO that translocates
to the nucleus (Fig. 5B) to directly induce dmyc-mRNA (Teleman et al.,
2008). In order to assess which pathways were sustained by dMyc in
the FB during starvation, we undertook a proteomic approach to
compare the proteomes of FBs from animals with different dMyc
levels in feeding and starving conditions. To conﬁrm that a more
sustained expression effectively correlates with an increase in protein
abundance, we focused our attention on the genes that were pre-
viously identiﬁed by quantitative RT-PCR analysis (Figs. 3B and 4H).
This analysis revealed that FBs expressing dMyc have signiﬁcantlyincreased Desat1, Pyruvate Kinase, Hexokinase-C and Glutamine
Synthetase1 protein levels (Table 2) and the expression of these
enzymes was further increased upon starvation (Table 2, Po0.0001,
using a Student's t test). Next we used the cg-Gal4 driver in combina-
tion with UAS-RNAi lines to analyze if the silencing of these genes in
the FB interferes with the ability of dMyc to induce systemic growth.
This analysis revealed that reduction of PyK or HK-C expression did
not affect the ability of dMyc to induce organismal growth, as dMyc
expression was able to signiﬁcantly induce growth (***Po0.001) as
measured in adults (Fig. 5C) and in pupae (Supplementary Fig. 9), even
when PyK or HK-C expressionwas reduced. On the contrary, reduction
of Desat1 completely blunted the ability of dMyc to inﬂuence body
size (Fig. 5C). Reduction of GS1 in the FB with the available RNAi line
resulted in pupal lethality, preventing us from further performing any
genetic analysis (Supplementary Fig. 9). Efﬁciency of the RNAi line in
FB was tested (Supplementary Fig. 10).
Reduction of Desat1 in the FB affects accumulation of TAGs and dMyc
resistance to starvation
In mice, mutation of scd1 reduces the level of TAG in the
adipose tissue resulting in leaner animals (Ntambi et al., 2002).
Fig. 5. Reduction of desaturase Desat1 affects dMyc systemic growth.
(A) Quantitative RT-PCR from the FB of cg-control third instar larvae in feeding or
starved for 24 h; actin5C was used as a control. *Po0.05, **Po0.01, ***Po0.001;
P-values were calculated from a Student t-test from at least four independent
experiments, (B) photographs of FB from animals in feeding or starved conditions
stained for dFOXO protein using anti dFOXO antibodies (material and methods). In
feeding condition dFOXO is located in the cytoplasm, starvation reduces systemic
insulin signaling allowing dFOXO to translocate into the nucleus, (C) measurement
of growth in the wing was calculated by measuring the total wing area, (material
and methods). Data are expressed as % of cg- control ﬂies using at least n¼20
female for each genotype. *Po0.05, **Po0.01, ***Po0.001; P-values were calcu-
lated from a Student t-test. Error bars represent the standard deviations.
Table 2
Quantitation and identiﬁcation for digest of proteins in FB from cg-dMyc and cg-
control larvae.
Protein name UniProt
ID
Ratio
fed
Ratio
starved
P-value
fed
P-value
starved
Desat1 Q7K4Y0 1.18 2.64 0.0012 8.86E−43
Pyruvate kinase KPYK 1.78 2.28 6.42E−07 2.72E−32
Hexokinase C Q7JYW9 1.41 1.98 0.003 3.82E−28
Glutamine
synthetase
GLNA1 1.38 1.43 1.52E−24 2.02E−21
The data are expressed as ratio from FB from cg-dMyc/cg-control animals in feeding
or after 24 h of starvation in PBS. P-values were calculated using ANOVA from three
independent experiments.
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results in smaller pupae (Supplementary Fig. 9) and adults with
reduced body size (Fig. 5C). The larval FB of cg-Desat1 RNAi
animals was composed of smaller cells (not shown) containing
less TAG (Fig. 6A, P¼4.5E-06; using a Student's t test). Expression
of dMyc increased the levels of TAG/protein of about 20% in both
cg- control and in cg-Desat1 RNAi; dMyc larval FB (Fig. 6A).
However, the content of TAG/protein in cg-Desat RNAi; dMyc
animals was lower then that of cg-control animals (Fig. 6A,
P¼0.003; using a Student's t test). We then analyzed whether
reduction of Desat1 could affect the ability of cg-dMyc animals to
resist starvation. This analysis showed that while cg-dMyc larvae
reached their half-life after 100 h of starvation, cg-Desat1-RNAi;
dMyc larvae reached the same point only after 48 h, with a similarrate as cg-Desat1-RNAi animals (Fig. 6B). Suggesting that reduction
of Desat1 compromises the ability of cg-dMyc larvae to survive on
a starvation regimen. cg-Desat1 RNAi animals are smaller, and their
level of TAG in the FB is reduced compared to cg-control larvae
(Fig. 6A). We then analyzed if reduction of Desat1 affected the size
of the fat cells. We use the UAS/Gal4 technique to induce ﬂip-out
clones expressing UAS-Desat1-RNAi under the actin promoter.
Clones were marked by co-expression of UAS-GFP and scored in
the FB. The size of Desat1-RNAi GFP-positive cells was compared to
that of wt GFP-negative cells surrounding the clones (Fig. 6C). This
analysis revealed that reduction of Desat1 decreased the cell-size
of the fat cells to 74% (compared to 100% in control wt cells)
(Po0.0001, using a t test). Expression of dMyc increased the size
of the cells to 179%, but when dMyc was expressed in combination
with Desat1 RNAi, its ability to induce growth was reduced to 139%
(Fig. 6D). However, the ability of dMyc to induce growth in a
Desat1 RNAi background (23+39%) was not signiﬁcantly different
to that measured in cg-control fat cells (79%), leading to the
conclusion that depletion of Desat1 in the FB did not affect dMyc's
ability to promote cell growth.Discussion
Here we show that modulation of dMyc activity in the fat body
(FB) controls animal size, recapitulating the phenotype of ubiqui-
tous dMyc expression (de la Cova et al., 2004; Johnston et al., 1999;
Pierce et al., 2004). This function is speciﬁc for dMyc activity since
other known growth inducers like CycD/Cdk4 or Rheb, do not
produce the same effect (Fig. 1E). (Arsham and Neufeld, 2006;
Wullschleger et al., 2006) Recent data showed that expression of
Rheb in Drosophila S2 cells stimulates ribosomal biogenesis and
cell size but did not promote glucose import (Hall et al., 2007). On
the contrary, we found that in the FB dMyc up-regulates the
expression of Glucose transporter-1 mRNA (Fig. 7), a condition that
may explain the increased intracellular concentration of glucose
(not shown). Stimulating protein synthesis alone is not sufﬁcient
to promote organismal size, indeed decreasing ribosomal biogen-
esis in the FB, using a mutation in the ribosomal-protein RpL14
Minute (3) 66D (Saeboe-Larssen et al., 1997) did not blunt dMyc's
ability to induce organismal growth (Supplementary Fig. 11),
supporting the idea that speciﬁc metabolic signals in addition to
protein synthesis are induced by dMyc in FB leading to increase in
body size.
The FB functions as a sensor for the amino acid concentration in
the hemolymph and in response to a diet rich in proteins,
produces humoral factors that control the release of DILP2 from
the brain (Geminard et al., 2009). Our data show that dMyc
expression in the FB inhibits the retention of DILP2 in the IPCs
during starvation (Fig. 2A), suggesting that an enhanced dMyc
activity in the FB mimics a fed state or is sufﬁcient to induce the
secretion of factors responsible for DILP2 release from the IPCs.
Accumulation of DILP2 in the IPCs leads to decreased trehalosemia
(level of circulating trehalose in the hemolymph) (Geminard et al.,
2009). The ability of cg-dMyc animals to decrease trehalosemia
and to affect the amount of DILP2 released during starvation,
together with the ﬁnding that DILP2 is required for the dMyc-
dependent systemic increase in size, led us to conclude that dMyc
control of systemic growth depends on the presence of circulating
DILPs. However the nature of the humoral factors governing DILP2
release and the mechanism that triggers the secretion of these fac
tors are not clear yet. To attempt at the identiﬁcation of the
pathways involved in their production, we analyzed by quantita-
tive RT-PCR the expression levels of key enzymes of glycolysis, glut
amine and lipid metabolic pathways upon dMyc induction in FB.
Fig. 6. Reduction of Desat1 affects dMyc's ability to accumulate TAG and to increase the size of cells in the FB. (A) Triglyceride (TAG) content in cells from FBs of the indicated
genotype; TAG concentration was normalized to the amount of protein; P-values were calculated from a Student t-test from three independent experiments, 10 larvae per
genotype were used in each experiment, (B) age-matched late L2 larvae were transferred in PBS, and larval viability was calculated every 12 h. P-values from a Student t-test
from three independent experiments Po0.001 was calculated for cg-control and cg-dMyc at all time points. cg-Desat1 RNAi and cg-Desat1 RNAi; dMyc animals are
signiﬁcantly smaller then cg-control animals (Po0.001), while no signiﬁcant difference was found between cg-Desat1 RNAi and cg-Desat1 RNAi; dMyc (P40.05). Error bars
represent the standard deviations, (C) actin ﬂip-out clones in FB expressing dMyc (a), Desat1-RNAi (b) or Desat1-RNAi; dMyc (c) are marked with GFP, nuclei are stained with
DAPI, (D) Numbers represent the size of cells from actin ﬂip-out clones in the FB; size is expressed as % of the control wild-type GFP negative cells surrounding the clones
(100). *Po0.05, **Po0.01, ***Po0.001; P-values were calculated from Student t-test from at least 40 cells. Error bars represent the standard deviations.
Fig. 7. Model of pathways induced by dMyc in the FB. Expression of dMyc in FB
favors the secretion of humoral factors responsible for the release of DILP2 from the
brain. We have identiﬁed potential pathways that are controlled by dMyc in the FB.
First, dMyc increases the expression of Fatty Acid Synthase (FAS), Acetyl CoA (ACC)
and of Desat1, responsible for the synthesis and modiﬁcation of fatty acids. Second,
dMyc induces glycolysis and glucose uptake by inducing the expression of
Hexokinases (HK-A and C) and Pyruvate Kinases (PyK), and of the Glucose
Transporter-1 (Glut-1). Third, dMyc favors the expression of Glutamate Synthase
(GS1) and Glutaminase, key enzymes in the synthesis of glutamine and glutami-
nolysis, suggesting a role in controlling glutamine ﬂux.
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Hexokinase-A, the putative homolog of human Hexokinase-IV or
glucokinase, Hexokinase-C, and of Pyruvate Kinase-mRNAs (Fig. 3B)
key enzymes that control glycolysis. In a mouse model for Type 2diabetes, the expression of c-Myc in the liver induced the transcrip-
tion of glycolytic enzymes and of the glucose transporter GLUT2,
resulting in decreased glycemia and counteracting streptozotocin
(STZ) induced diabetes (Riu et al., 1996). Similarly, we found that cg-
dMyc larvae, grown on a high sugar diet (1 M sucrose), were able to
reduce their level of trehalosemia (Fig. 3C). Our results could be
explained by the ability of dMyc to increase Glut-1 mRNA that
favored glucose uptake, and by dMyc's ability to increase the rate
of glucose consumption via glycolysis.
By quantitative PCR analysis we revealed that expression of
dMyc in the FB upregulates Glutaminase and Glutamine Synthetase
(GS1) mRNAs, key regulators in glutamine metabolism (Fig. 3B). In
addition, we found an increase in the expression of the Drosophila
orthologue of the vertebrate LAT1/SLC1A5 also called minidiscs
(mnd) (Martin et al., 2000) and of SLC38/11, two members of the
L-and N-type family of amino acid transporter-1 (Mackenzie and
Erickson, 2004) (Supplementary Fig. 12). In vertebrates, LAT1/
SLC1A5 controls the efﬂux of L-glutamine that precedes the import
of essential amino acids to induce the activation of mTOR signaling
(Nicklin et al., 2009), while in ﬂies, mnd, which is highly expressed
in the FB, was shown to function non autonomously to control
organismal size (Martin et al., 2000). With this data we could
hypothesize that dMyc in the FB controls glutamine ﬂux to favor
the uptake of essential amino acids resulting in activation of
glutamine metabolism. Glutamine ﬂux is also controlled by
Glutamine Synthetase1, and very recently GS1 was identiﬁed in
vertebrates, as a direct target of FOXO-3 to maintain glutamine
homeostasis and to promote autophagy leading to cell
survival (van der Vos et al., 2012). Because in the FB, dFOXO is
necessary to sustain dmyc-mRNA expression during starvation
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dMyc axis functions to control GS1 activity to regulate glutamine-
dependent pathways necessary for animal survival.
dMyc expressing animals have an increased content of TAG and
glucose in the whole body that correlates with increased tran-
scriptional levels of Fatty Acid Synthase (FAS) and Acetyl CoA (ACC).
In the vertebrate liver and adipocytes FAS and ACC are transcrip-
tionally regulated in response to glucose concentration by the
Carbohydrate Response-Element Binding Protein, Max-Like pro-
tein (Mlx) and MondoA (Uyeda and Repa, 2006). Mlx and MondoA
form heterodimers that bind to the E-box sequences in the ACC
and FAS promoter to induce their expression, and to reduce
glucose uptake (Billin and Ayer, 2006; Billin et al., 2000). In the
presence of high levels of glutamine, the activity of Mlx/Mondo
heterodimers decreases and their negative effect on glucose
uptake is relieved, resulting in increased glucose concentration
(Kaadige et al., 2009). In addition, Drosophila Mondo interacts
genetically with dMyc (Billin and Ayer, 2006) raising the possibi-
lity that misexpression of dMyc may change the stoichiometry of
Mondo/Mlx heterodimers to control ACC and FAS and glucose
uptake in the FB.
In support to the data on the transcriptional targets induced by
dMyc in the FB, our analysis of proteomes of fat bodies from
animals with different dMyc levels revealed a signiﬁcant increase
of the glycolytic enzymes (PyK and HK-C), Glutamine Synthetase
(GS1) and Desat1 particularly during starvation (Table 2). How-
ever, to our surprise, we found that only reducing Desat1 blunted
the ability of dMyc to induce organismal growth (Fig. 5C). Desat1,
or SCD1 in vertebrates, is the rate limiting enzyme that catalyzes
the biosynthesis of monosaturated fatty acids, components of
triglycerides and phospholipids (Mauvoisin and Mounier, 2011).
In Drosophila Desat1 protein was increased in proteomes from FB
from starved animals, while desat1 mutant animals were found
defective in autophagy, a survival mechanism that is activated
during starvation (Kohler et al., 2009). We found that reduction of
Desat1 reduced the ability of fat cells to store TAG, and cg-Desat1-
RNAi animals were less resistant to starvation. We found Desat1
activity necessary for dMyc’s ability to induce fat synthesis and for
the animal to resist starvation (Fig. 6). One possible explanation is
that reduction of Desat1 unable animals to accumulate TAG in their
fat cells, thus their storage necessary to resist starvation. In our
model, we place Desat1 function downstream of dMyc activity
(Fig. 7), however we did not ﬁnd dMyc binding sites in the
promoter region of Desat1, suggesting that dMyc is acting indir-
ectly to control desat1mRNA expression. In human, SCD1/Desat1
plays a relevant role in carcinogenesis to control de-novo synthesis
of lipids and its level is upregulated in different tumors (Igal, 2010;
Scaglia et al., 2009). FAS and ACC expression are also increased in
cancer cells, where their ability to promote de novo synthesis of
lipids provides a growth advantage to the tumor cells (Menendez
and Lupu, 2007). Myc's ability to control FAS and ACC and SCD1/
Desat1 expression suggest a novel function for Myc to control lipid
metabolism and survival that may be relevant in normal and
pathological conditions.
Our studies are centered to uncover novel metabolic pathways
induced by dMyc in the FB. dMyc expression in this organ is
developmentally regulated by ecdysone, which reduces dmyc
mRNA in late third instar to constrain growth (Delanoue et al.,
2010). At this developmental time the systemic reduction of
insulin signaling activates dFOXO, which results in dMyc upregu-
lation (Fig. 5 A) (Teleman et al., 2008). We think that opposite
mechanisms may coexist in the FB to regulate dMyc expression.
Activation of these pathways is regulated by the metabolic status
of the animals and by their developmental stage. For example, at
the end of larval development growth is reduced and dMyc
expression needs to be shut down, however if the animal is instarvation and the nutrients are reduced, dMyc expression is
induced to ensure the activation of speciﬁc metabolic processes
necessary for the animal to survive.
In conclusion, our ﬁndings establish a novel link between dMyc
function in the fat body and the non-cell-autonomous control of
growth, metabolism, and survival of the organism. Our data
identify two potential signals that are inﬂuenced by dMyc
(Fig. 7). The ﬁrst mimics the non-autonomous control of DILP2
release from the brain induced by humoral factors produced by
the FB during feeding. The second identiﬁes Desat1 as a novel
component for dMyc activity, that may be relevant for its function
in controlling fatty acid metabolism and de-novo synthesis of
lipids as a mechanism of cell survival. These observations may
have signiﬁcant implications for our understanding not only of the
systemic control of growth and metabolism but also create the
need to explore Myc function at the physiological level in control-
ling lipid homeostasis and metabolism in diseases such as diabetes
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